Sterling Capital Management
PBLS

Sterling Capital Management’s Parabilis Medicines Inc PBLS Stock Holding History

Sterling Capital Management’s Portfolio PBLS Stock Details PBLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$35.4K Buy
+1,097
New +$38.3K ﹤0.01% 1915

Other funds holding PBLS

Tema ETFs
Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
CX Institutional
CX Institutional Auburn, Indiana $3.69B AUM 15.82% 1-Year Est. Return
Physician Wealth Advisors
Physician Wealth Advisors Midvale, Utah $869M AUM 17.6% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Sterling Capital Management's PBLS Position: Q3 2026 in Review

Sterling Capital Management opened a new position in Parabilis Medicines Inc (PBLS) in Q3 2026: 1,097 shares worth $35.4K. The stake represents ﹤0.01% of the portfolio and ranks #1915 among its holdings.

7 funds tracked by Wall St. Rank hold PBLS as of Q3 2026.

  • Sterling Capital Management held 1,097 shares of Parabilis Medicines Inc worth $35.4K as of Q3 2026.
  • Parabilis Medicines Inc was a new Sterling Capital Management position in Q3 2026.
  • Parabilis Medicines Inc made up ﹤0.01% of Sterling Capital Management's portfolio in Q3 2026, its #1915 holding.
  • 7 funds tracked by Wall St. Rank held Parabilis Medicines Inc as of Q3 2026.

Based on Sterling Capital Management's 13F filing for Q3 2026, filed 22 Oct 2026.